DiaMedica Therapeutics (DMAC) Other financing activities (2018 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Other financing activities came in at $420000.0 in Q1 2026, up 346.81% year-on-year from $94000.0 in Q1 2025, and up 51.08% quarter-over-quarter from $278000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Other financing activities (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Other financing activities history runs 6 years deep, the most recent figure standing at $420000.0 for Q1 2026.
- On a quarterly basis, Other financing activities rose 346.81% year-over-year to $420000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 278.86% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 290.62% from the prior year.
- Other financing activities climbed to $420000.0 in Q1 2026 per DMAC's latest filing, from $278000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $465000.0 in Q3 2025 and bottomed at $7000.0 in Q2 2024.
- The 3-year median for Other financing activities is $144500.0 (2024), against an average of $209500.0.
- Biggest YoY gain for Other financing activities was 2228.57% in 2025; the steepest drop was 126.02% in 2025.
- Year by year, Other financing activities stood at $123000.0 in 2024, then surged by 126.02% to $278000.0 in 2025, then surged by 51.08% to $420000.0 in 2026.
- Per Business Quant, the three latest DMAC Other financing activities figures stand at $420000.0 (Q1 2026), $278000.0 (Q4 2025), and $465000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | DiaMedica Therapeutics | 364.72 Mn | 364.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 420,000.00 |
| Mar 31, 2026 | 420,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 465,000.00 |
| Sep 30, 2025 | 465,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Mar 31, 2025 | 94,000.00 |
| Mar 31, 2025 | 94,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2021 | 244,000.00 |
| Mar 31, 2021 | 244,000.00 |
| Dec 31, 2020 | 29,000.00 |
| Dec 31, 2020 | 29,000.00 |